Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow‐derived mesenchymal stem/stromal cells

Human bone marrow‐derived mesenchymal stem/stromal cells (BM‐MSCs) represent promising stem cell therapy for the treatment of type 2 diabetes mellitus (T2DM), but the results of autologous BM‐MSC administration in T2DM patients are contradictory. The purpose of this study was to test the hypothesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Liem Thanh, Hoang, Duc M., Nguyen, Kien T., Bui, Duc M., Nguyen, Hieu T., Le, Hong T.A., Hoang, Van T., Bui, Hue T. H., Dam, Phuong T.M., Hoang, Xuan T.A., Ngo, Anh T.L., Le, Hang M., Phung, Nhi Y., Vu, Duc M., Duong, Trung T., Nguyen, Tu D., Ha, Lien T., Bui, Hoa T.P., Nguyen, Hoa K., Heke, Michael, Bui, Anh V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380443/
https://www.ncbi.nlm.nih.gov/pubmed/34080789
http://dx.doi.org/10.1002/sctm.20-0506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380443/
https://www.ncbi.nlm.nih.gov/pubmed/34080789
http://dx.doi.org/10.1002/sctm.20-0506

Ejemplares similares